Clinical research

Effect of early statin and selective cyclooxygenase-2 inhibitor therapy on C-reactive protein level after percutaneous coronary angioplasty in unstable angina

EuroIntervention 2005;1:315-320 - DOI10.4244/EIJV1I3A52.

Dariusz Dudek*, MD, PhD; Grzegorz Heba MD, PhD; Jacek Legutko MD, PhD; Michal Chyrchel MD; Tomasz Rakowski MD; Grzegorz L. Kaluza, MD PhD; Jacek S. Dubiel MD, PhD

Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland

Aims: We evaluated the effect of cyclooxygenase-2 inhibitor rofecoxib added to atorvastatin, initiated immediately after percutaneous coronary angioplasty (PCI), on C-reactive protein (CRP) and interleukin-6 (IL-

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

unstable anginaangioplastyinflammatory markersstatinscyclooxygenase-2 inhibitors

Share on Facebook Share on Twitter Share on Linkedin